dipyridamole has been researched along with Nephrotic Syndrome in 27 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole was used in 30 cases of nephrotic syndrome, mostly of intractable type." | 9.04 | Dipyridamole therapy in the nephrotic syndrome. ( Koyama, A; Narita, M; Sano, M; Shishido, H; Suzuki, H; Tojo, S; Tsuchida, H; Tsuchiya, T; Yamamoto, S, 1978) |
| "Dipyridamole was used in 30 cases of nephrotic syndrome, mostly of intractable type." | 5.04 | Dipyridamole therapy in the nephrotic syndrome. ( Koyama, A; Narita, M; Sano, M; Shishido, H; Suzuki, H; Tojo, S; Tsuchida, H; Tsuchiya, T; Yamamoto, S, 1978) |
| "Nine cases of nephrotic children associated with focal segmental glomerulosclerosis who had failed to respond to prednisone and cyclophosphamide therapy and showed sign of progressive deterioration of renal function, were subjected to the therapeutic combinations of antiplatelet agents + prednisone +/- anticoagulant agents." | 3.66 | A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis. ( Futrakul, P, 1980) |
| "With treatment of prednisolone, an angiotensin-converting enzyme inhibitor, and an angiotensin II receptor-blocker, his proteinuria markedly decreased and renal function was stabilized." | 2.43 | Nephrotic syndrome and IgA nephropathy in polycystic kidney disease. ( Gejyo, F; Hiura, T; Kawabe, S; Miyamura, S; Nishi, S; Saeki, T; Ueno, M; Yamazaki, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (62.96) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Souvannamethy, P | 1 |
| Hiura, T | 1 |
| Yamazaki, H | 1 |
| Saeki, T | 1 |
| Kawabe, S | 1 |
| Ueno, M | 1 |
| Nishi, S | 1 |
| Miyamura, S | 1 |
| Gejyo, F | 1 |
| Zhong, ZM | 1 |
| Yu, L | 1 |
| Weng, ZY | 1 |
| Hao, ZH | 1 |
| Zhang, L | 1 |
| Zhang, YX | 1 |
| Dong, WQ | 1 |
| Okada, S | 1 |
| Kurata, N | 1 |
| Ota, Z | 1 |
| Ofuji, T | 1 |
| Cameron, JS | 1 |
| Kincaid-Smith, P | 2 |
| Chen, WY | 1 |
| Chen, TJ | 1 |
| Yen, TS | 1 |
| Hsieh, BS | 1 |
| Tsai, TJ | 1 |
| Hsu, HC | 1 |
| Donadio, JV | 1 |
| Ishikawa, H | 2 |
| Honjo, A | 2 |
| Hayashi, M | 2 |
| Hamaguchi, T | 2 |
| Morita, T | 2 |
| Shindo, T | 1 |
| Tetsutani, T | 1 |
| Yamamoto, T | 1 |
| Okubo, H | 1 |
| Oka, G | 2 |
| Futrakul, P | 1 |
| Kartasheva, VI | 1 |
| Wu, ZL | 1 |
| Zhou, KR | 1 |
| Liao, LT | 1 |
| Nikiforova, OV | 1 |
| Kozlovskaia, NL | 1 |
| Rogov, VA | 1 |
| Zozulia, OV | 1 |
| Miroshnichenko, NG | 1 |
| Yasukawa, K | 1 |
| Kohno, M | 1 |
| Ohmoto, A | 1 |
| Matsuyama, R | 1 |
| Kacprzyk, F | 1 |
| Chrzanowski, W | 1 |
| Kubala, L | 1 |
| Orłowski, Z | 1 |
| Woo, KT | 1 |
| Lindeman, RD | 1 |
| Tojo, S | 3 |
| Narita, M | 2 |
| Koyama, A | 2 |
| Sano, M | 2 |
| Suzuki, H | 2 |
| Tsuchiya, T | 2 |
| Tsuchida, H | 2 |
| Yamamoto, S | 2 |
| Shishido, H | 2 |
| Tesutani, T | 1 |
| Yamamoto, M | 1 |
| Fujimoto, Y | 1 |
| Okubo, A | 1 |
| Shulutko, BI | 1 |
| Ueda, Y | 1 |
| Hatano, M | 1 |
| Furukawa, T | 1 |
| Yoshinaga, K | 1 |
| Kinoshita, Y | 1 |
| Takeuchi, J | 1 |
| Kato, E | 1 |
| Ohno, J | 1 |
| Kobayashi, K | 1 |
| Abe, H | 1 |
| Omae, S | 1 |
| Watanabe, K | 1 |
| Thiele, KG | 1 |
| Matsui, N | 1 |
| Murphy, BF | 1 |
| McDonald, I | 1 |
| Fairley, KF | 1 |
| Kincaid-Smith, PS | 1 |
4 reviews available for dipyridamole and Nephrotic Syndrome
| Article | Year |
|---|---|
Nephrotic syndrome and IgA nephropathy in polycystic kidney disease.
Topics: Aged; Biopsy; Dipyridamole; Glomerulonephritis, IGA; Humans; Kidney; Losartan; Male; Nephrotic Syndr | 2006 |
Platelets in glomerular disease.
Topics: Animals; Antigen-Antibody Complex; Blood Platelets; Dipyridamole; Glomerulonephritis; Humans; Nephro | 1984 |
Current therapeutic strategies in glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoag | 1999 |
[Focal glomerulosclerosis (review of the literature and personal observations)].
Topics: Adult; Basement Membrane; Complement System Proteins; Dipyridamole; Female; Glomerulonephritis; Glom | 1979 |
6 trials available for dipyridamole and Nephrotic Syndrome
| Article | Year |
|---|---|
[Therapeutic effect of Ginkgo biloba leaf extract on hypercholestrolemia in children with nephrotic syndrome].
Topics: Adolescent; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Ginkgo biloba; | 2007 |
[Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dipyridamole; Female; Glomerulosclerosis | 1997 |
Dipyridamole therapy in the nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Dipyridamole; Drug Evaluation; Drug Therapy, Comb | 1978 |
[The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)].
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Dipyridamole; Double-Blind Metho | 1979 |
[Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)].
Topics: Adolescent; Adult; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Humans; Male | 1979 |
Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
Topics: Cyclophosphamide; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Female; Glo | 1992 |
17 other studies available for dipyridamole and Nephrotic Syndrome
| Article | Year |
|---|---|
Management of Nephrotic Syndrome: A Case Report from Lao PDR.
Topics: Adult; Albumins; Dipyridamole; Female; Furosemide; Humans; Iron; Laos; Methylprednisolone; Nephrotic | 2017 |
Effect of dipyridamole on proteinuria of nephrotic syndrome.
Topics: Adult; Dipyridamole; Humans; Male; Nephrotic Syndrome; Proteinuria | 1981 |
The treatment of glomerulonephritis.
Topics: Adolescent; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; | 1980 |
Platelet aggregation and dipyridamole therapy in nephrotics.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Dipyridamole; Dose-Response Relationship, Drug; Epin | 1982 |
Primary glomerular disease: to treat or not to treat.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, | 1982 |
Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Dipyridamole; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nephro | 1982 |
A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Cyclophosphamide; Dipyridamole; Drug T | 1980 |
[Comparative effectiveness of different therapeutic regimens in lupus nephritis in children and adolescents].
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Evaluati | 1980 |
Thrombolytic therapy of renal vein thrombi and follow-up.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Dipyridamole; Female; Follow-Up Studies; Humans | 1994 |
[The successful therapy of an exacerbation of mesangioproliferative nephritis during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differ | 1995 |
[Henoch-Schönlein nephritis with nephrotic syndrome during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Dipyridamole; Female; Heparin; HLA-DQ Antigens; HLA | 1996 |
Drug treatment of the chronic idiopathic glomerulopathies.
Topics: Adrenal Cortex Hormones; Alkylating Agents; B-Lymphocytes; Chronic Disease; Dipyridamole; Folic Acid | 1977 |
[Dipyridamole therapy in the nephrotic syndrome (author's transl)].
Topics: Adolescent; Adult; Aged; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; | 1978 |
[Special pharmacotherapy of primary glomerulonephritis in the adult].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anticoagulants; Azathioprine; Cyclophosphamide; Dipyrid | 1975 |
[Renal vein thrombosis].
Topics: Dipyridamole; Heparin; Humans; Nephrotic Syndrome; Renal Veins; Thrombosis; Urokinase-Type Plasminog | 1992 |
[Approach to the treatment of intractable nephrotic syndrome].
Topics: Cyclophosphamide; Dipyridamole; Glomerulonephritis; Humans; Immunosuppressive Agents; Indomethacin; | 1986 |
The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.
Topics: Anticoagulants; Biopsy; Cyclophosphamide; Dipyridamole; Drug Combinations; Erythrocyte Count; Female | 1972 |